Over the last several years, urgent care has moved out of the easy-growth phase. Labor costs rose quickly. Reimbursement pressure increased. Capital became more cautious. For many owners, the focus shifted from adding locations to protecting margins and keeping teams intact.
As we move through 2026, the market feels different. Buyers are still active, but they are asking tougher questions, and more of them. Capital is still available, but it is being deployed more selectively, with greater emphasis on predictability, durability, and operational discipline. Owners who have built stable, well-managed operations and are open to a transaction in the next few years are positioned well in this environment.
Demand and Cost Pressure Continue to Anchor the Model
The structural drivers behind urgent care remain intact. Emergency departments are still crowded in many regions, and access to primary care continues to tighten as physician shortages persist. Patients expect immediate evaluation for non-life-threatening conditions and have grown accustomed to extended hours and convenient access points.
Urgent care continues to function as a “pressure-release valve” for the broader healthcare system. Health systems rely on it to redirect lower-acuity cases away from hospitals. Payers depend on it as a cost-control mechanism. Employers value it for occupational health and episodic injury care because it balances accessibility with affordability. In a system under constant cost pressure, urgent care aligns closely with where incentives are moving: toward access, efficiency, and cost containment. It offers access patients want at a price payers and employers can justify.
Buyers looking at urgent care today are less interested in short-term spikes and more interested in predictability. They want to see steady visit patterns, a reliable payer mix, and evidence that performance holds up when volumes dip or staffing tightens. Remember: Disciplined buyers plus prepared sellers equals opportunity.
Fragmentation and Execution Are Driving Transaction Strategy
Despite a decade of consolidation, urgent care remains highly fragmented. Many organizations are founder-led, regionally concentrated, and dependent on informal management structures. That fragmentation still creates opportunity, but buyers are no longer forgiving of weak infrastructure. In fragmented markets, execution — not scale alone — has become the primary differentiator.
In prior cycles, some acquirers leaned heavily on rapid expansion assumptions and financial structuring. The current market rewards operational discipline. Buyers are scrutinizing revenue cycle performance, staffing efficiency, and leadership depth. They want to understand how a business performs when volumes fluctuate and how reliably it converts visits into consistent cash flow.
This is increasingly an execution business. Throughput optimization, centralized billing, disciplined scheduling, and standardized clinical protocols can meaningfully improve performance without adding new locations. Buyers see upside in organizations that have already tightened these levers and are cautious around those that remain overly dependent on founder oversight or inconsistent site-level management.
Strategic Value Extends Beyond Standalone Earnings
Urgent care’s appeal is not limited to its direct profitability. It often serves as an entry point into employer services and occupational health programs. It feeds downstream specialties like imaging, orthopedics, and primary care. For health systems and risk-bearing entities, urgent care provides geographic access and patient engagement that support broader care strategies.
That adjacency continues to attract interest from multiple buyer categories, including health systems, payers, and well-capitalized private platforms. For the right buyer, urgent care is more than a revenue stream. It is an entry point into a broader care network, supporting employer services, downstream specialties, and population engagement.
At the same time, disciplined buyers are clear about what they are not underwriting. Few buyers are projecting reimbursement expansion or a return to pandemic-era margin levels. Brand presence alone rarely commands pricing leverage without operational substance behind it. The emphasis now rests squarely on fundamentals: clean financial reporting, steady performance across locations, effective labor management, and leadership teams capable of sustaining operations through transition.
A Market That Rewards Preparation
For owners who are thinking about selling in the not-so-distant future, this is a market that rewards preparation. Buyers are spending more time in diligence than they did a few years ago. They want to understand how the business performs month to month, how labor is managed, how collections are tracked, and who is really running the operation.
Owners who anticipate those questions can get ahead of the process. Strengthening the revenue cycle, clarifying who is accountable for performance, tightening reporting, and addressing succession are not cosmetic changes. They reduce uncertainty. And in transactions, lower uncertainty typically leads to better outcomes.
Questions Urgent Care Owners Should Be Asking Themselves Now
Owners who are even moderately open to a transaction in the next few years should evaluate their organizations through a buyer’s lens. In my experience, the strongest outcomes occur when preparation begins well before a formal sale process.
Consider:
- How consistent is performance across locations? Are throughput, labor ratios, and collections tightly managed, or do results vary significantly by site?
- Is your revenue cycle centralized and data-driven, or does performance depend heavily on individual managers?
- Would your leadership team operate effectively if you stepped back from daily oversight?
- Are your financial statements clean, transparent, and ready for third-party diligence?
- Have you addressed succession planning and documented operational processes in a way that reduces transition risk?
In transaction processes I have led, these are some of the areas that most meaningfully influence valuation discussions.
The urgent care sector has become more disciplined, but buyer interest remains steady. Capital is engaged, just more selective. Access challenges are not going away, cost pressure still favors urgent care, and the market remains fragmented enough to reward operators who have built real infrastructure.
If you are an urgent care owner open to a transaction, the window is defined less by market excitement and more by how well the business is actually running. Preparation creates optionality. If you were evaluating your organization through the lens of a disciplined buyer today, what would clearly signal strength, and what would you want to improve before entering the market?

J. Blake Peart
J. Blake Peart, RRT, CM&AA, is a managing director for healthcare M&A advisory firm VERTESS where his work includes working with healthcare business owners to bring their organizations to market. He has served as CEO for multiple hospitals of Fortune 500 companies, CEO for several large ambulatory surgery centers, and assistant professor at LSU, and sat on the boards for SCA Health and Kindred Healthcare.






